Signature Equity Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Signature Equity Partners's MDT Position: Q2 2026 in Review
Signature Equity Partners increased its Medtronic (MDT) stake by 31% in Q2 2026, buying an estimated $6.53K and bringing the position to 344 shares worth $26.9K. The position accounts for 0.01% of the portfolio, ranked #574.
Signature Equity Partners first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $41.4K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Signature Equity Partners held 344 shares of Medtronic worth $26.9K as of Q2 2026.
- Signature Equity Partners bought 81 Medtronic shares in Q2 2026, an estimated $6.53K.
- Medtronic made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #574 holding.
- Signature Equity Partners first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
- Signature Equity Partners's Medtronic position peaked at $41.4K in Q4 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.